Gagandeep Singh

City Of Hope National Medical Center, City of Hope

Papers

9

Total Citations

274

H-Index

8

About

Dr. Gagandeep Singh is a leading surgical oncologist whose research focuses on advancing minimally invasive robotic surgery for gastrointestinal and hepatopancreatobiliary cancers. His major contributions center on demonstrating the safety, oncologic efficacy, and cost-effectiveness of robotic approaches for complex procedures, including distal pancreatectomy, liver resection, and total pancreatectomy. Notably, his 2018 study analyzing the National Cancer Database provided critical evidence that robotic distal pancreatectomy yields comparable oncologic outcomes to laparoscopic approaches, while his work on robotic liver resection has pushed the boundaries toward rapid recovery and even outpatient hepatectomy. Dr. Singh’s research also highlights the importance of patient selection, showing that frail patients derive the greatest benefit from minimally invasive techniques, and that hospital-level factors strongly influence robotic adoption. With papers accumulating over 270 citations, his work has shaped perioperative and oncologic safety standards. His landmark study on over 10,000 robotic surgeries at a comprehensive cancer center further underscores his commitment to optimizing outcomes and reducing complications, establishing him as a key voice in the evolution of robotic surgical oncology.

Research Focus

Key Achievements

8
H-Index
9
Papers
274
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic outcomes after robot‐assisted versus laparoscopic distal pancreatectomy: Analysis of the National Cancer Database
64 citations · 2018
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: City Of Hope National Medical Center, City of Hope

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago